Request a Quotation

Your Contact Information
Peptides Logo
Support and counselling under:
+49(0)3302 - 2022000 info@peptides.de
€0.00*
Structure of BCL-2L1 165-173 (HLA-A*03:01)
Logo for Cancer
Cancer

BCL-2L1 165-173 (HLA-A*03:01) RIAAWMATY

Product number: EP11085_1

€105.00*

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart

Description

The peptide BCL-2L1 165-173 (HLA-A*03:01) with the amino acid sequence RIAAWMATY is a linear peptidic epitope (epitope ID 991046) studied as part of Bcl-2-like protein 1 (UniProt:Q07817) from Homo sapiens (human).

BCL-2L1 165-173 (HLA-A*03:01) has been studied for immune reactivity in publications and has been tested in T cell assays and MHC ligand assays.

TechData

Sequence: RIAAWMATY
Gene: BAD
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 1 mg
Counterion: TFA
Protein: Bcl2-associated agonist of cell death
Species: Human
Allele: HLA-A*03:01
Application: Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry
Indication: Cancer
Purity: 95% HPLC-MS

Documents

Material data sheet Safety data sheet Storage and handling of peptides Probing of membranes with HRP
Skip product gallery

More BCL-2 peptides

BCL-2 180-189 (HLA-A*02:01)
BCL-2 180-189 (HLA-A*02:01)
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide/MHC complex composed BCL-2-derived peptide of YLNRHLHTWI sequence covering 180-189 and A*02:01 molecule.

From €105.00*
Details
BCL-2 208-217 (HLA-A*02:01)
BCL-2 208-217 (HLA-A*02:01)
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide/MHC complex composed BCL-2-derived peptide of PLFDFSWLSL sequence covering 208-217 and A*02:01 molecule.

From €105.00*
Details
Bcl-2 214-223 (HLA-A*02:01)
Bcl-2 214-223 (HLA-A*02:01)
Bcl-2 peptide WLSLKTLLSL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from B cell lymphoma 2 (Bcl-2) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.

From €105.00*
Details
BCL-2 85-93 (HLA-A*02:01)
BCL-2 85-93 (HLA-A*02:01)
The peptide BCL-2 85-93 (HLA-A*02:01) with the amino acid sequence ALSPVPPVV is a linear peptidic epitope (epitope ID 2889) studied as part of Apoptosis regulator Bcl-2 (UniProt:P10415) from Homo sapiens (human).BCL-2 85-93 (HLA-A*02:01) has been studied for immune reactivity in publication and has been tested in MHC ligand assay.

From €105.00*
Details
BCL-2A1 15-23 (HLA-A*24:02)
BCL-2A1 15-23 (HLA-A*24:02)
This peptides are used for the detection of antigen-specific T-cell populations. MHC-peptide tetramer complexes recognize antigen specific T-cells at the single cell level, allowing for accurate measurements of the functional immune response in cancer, infectious diseases, and autoimmune diseases.ï¾  Due to their increased avidity, MHC tetramers stably bind to cognate TcRs and are evaluated using flow cytometry.

From €105.00*
Details
This website uses cookies to ensure the best experience possible. More information...